Ascom Holding AG (XSWX:ASCN) Research & Development: CHF31.1 Mil (TTM As of Dec. 2025)


XSWX:ASCN Ascom Holding AG XSWX:ASCN
69 GF Score
Price CHF5.99
GF Value CHF5.82
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Ascom Holding AG Research & Development?

Ascom Holding AG XSWX:ASCN +4.90% 69 Research & Development is CHF31.1 Mil as of Dec. 2025. GuruFocus rates XSWX:ASCN with a GF Score™ of 69/100 and a GF Value™ of CHF5.82 (Fairly Valued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Ascom Holding AG's Research & Development for the six months ended in Dec. 2025 was CHF15.5 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was CHF31.1 Mil.

Ascom Holding AG  (XSWX:ASCN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Ascom Holding AG Research & Development Related Terms

Ascom Holding AG Research & Development Historical Data

* Premium members only.

The historical data trend for Ascom Holding AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascom Holding AG Research & Development Chart

Ascom Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.20 26.70 26.60 28.60 31.10

Ascom Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.80 13.50 15.10 15.60 15.50
XSWX:ASCN
69GF Score
Ascom Holding AG XSWX:ASCN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascom Holding AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF31.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of CHF31.1 Mil mean?
Ascom Holding AG (XSWX:ASCN) has a Research & Development of CHF31.1 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Ascom Holding AG and its competitors.
Is Ascom Holding AG's Research & Development too high?
Ascom Holding AG's current Research & Development is CHF31.1 Mil. Overall, Ascom Holding AG has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ascom Holding AG's Research & Development compare to VEEV and BTSG?
Ascom Holding AG's Research & Development of CHF31.1 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Ascom Holding AG and its competitors. Ascom Holding AG's current Research & Development is CHF31.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascom Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ascom Holding AG (XSWX:ASCN) is currently considered Fairly Valued. The stock's GF Value™ is CHF5.82, compared to a current price of CHF5.99 — trading 2.9% above its estimated fair value. The current Research & Development is CHF31.1 Mil. Ascom Holding AG's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Ascom Holding AG (XSWX:ASCN), the current Research & Development is CHF31.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ascom Holding AG (XSWX:ASCN) Overvalued in 2026?

Based on GuruFocus' analysis, Ascom Holding AG stock appears to be overvalued. The current stock price of CHF5.99 is trading 2.9% above its estimated GF Value™ of CHF5.82. GuruFocus considers Ascom Holding AG to be Fairly Valued.

Key valuation signals for XSWX:ASCN:

  • Research & Development: CHF31.1 Mil
  • GF Value™: CHF5.82 vs. price of CHF5.99 (2.9% above fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the XSWX:ASCN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ascom Holding AG Business Description

Address Zugerstrasse 32, Baar, CHE, 6340
Ascom Holding AG is a solutions provider of ICT and mobile workflow solutions in the healthcare and enterprise sectors. The company consists of a business unit, the purpose of which is to use its product and solutions portfolio and software architecture capabilities to devise integration and mobilization solutions that provide digitalized, complete, and efficient workflows for healthcare as well as for industry, security, and retail sectors. The company has three segments OEM, Enterprise, and Healthcare. It derives a majority of revenue from the healthcare segment.
69GF Score

Get the complete analysis for XSWX:ASCN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF5.99
Price
CHF5.82
GF Value